Personalis (NASDAQ:PSNL) Upgraded to “Hold” at Zacks Research

Zacks Research upgraded shares of Personalis (NASDAQ:PSNL) from a strong sell rating to a hold rating in a research note released on Monday morning,Zacks reports.

Other analysts have also recently issued research reports about the company. TD Cowen restated a “buy” rating on shares of Personalis in a research report on Wednesday, July 15th. Lake Street Capital cut Personalis from a “buy” rating to a “hold” rating and set a $16.25 price objective on the stock. in a research report on Monday, July 20th. Wall Street Zen downgraded Personalis from a “hold” rating to a “sell” rating in a research note on Saturday, June 13th. Craig Hallum lowered shares of Personalis from a “buy” rating to a “hold” rating and set a $16.25 target price for the company. in a report on Monday, August 24th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Personalis in a research note on Friday, July 17th. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $14.54.

Personalis Trading Down 3.5%

Shares of NASDAQ PSNL opened at $16.60 on Monday. The firm has a 50 day moving average of $14.68 and a 200 day moving average of $10.41. The firm has a market capitalization of $1.74 billion, a price-to-earnings ratio of -15.23 and a beta of 2.31. Personalis has a 12-month low of $4.95 and a 12-month high of $18.89.

Personalis (NASDAQ:PSNL) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.04). The company had revenue of $22.36 million during the quarter, compared to analysts’ expectations of $16.69 million. Personalis had a negative return on equity of 46.47% and a negative net margin of 153.84%. Sell-side analysts predict that Personalis will post -1.07 EPS for the current year.

Insider Buying and Selling

In other Personalis news, CEO Christopher Hall sold 100,000 shares of the company’s stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $15.08, for a total transaction of $1,508,000.00. Following the sale, the chief executive officer directly owned 235,986 shares in the company, valued at $3,558,668.88. This represents a 29.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Aaron Tachibana sold 4,982 shares of Personalis stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $14.00, for a total value of $69,748.00. Following the completion of the transaction, the chief financial officer owned 198,833 shares of the company’s stock, valued at approximately $2,783,662. This trade represents a 2.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 256,233 shares of company stock worth $3,568,236. Company insiders own 4.20% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of PSNL. WINTON GROUP Ltd bought a new position in Personalis during the second quarter valued at $496,000. Engineers Gate Manager LP bought a new position in Personalis during the 2nd quarter valued at about $1,552,000. Squarepoint Ops LLC purchased a new stake in Personalis in the 2nd quarter worth about $319,000. Arizona State Retirement System boosted its position in shares of Personalis by 28.2% during the second quarter. Arizona State Retirement System now owns 18,766 shares of the company’s stock valued at $251,000 after buying an additional 4,131 shares during the period. Finally, California State Teachers Retirement System increased its stake in Personalis by 37,061.5% in the second quarter. California State Teachers Retirement System now owns 1,008,564 shares of the company’s stock worth $13,515,000 after purchasing an additional 1,005,850 shares during the period. 61.91% of the stock is owned by hedge funds and other institutional investors.

About Personalis

Personalis, Inc (NASDAQ: PSNL) is a clinical‐stage genomics company that develops and markets advanced next‐generation sequencing (NGS) services and assays designed to accelerate precision medicine. The Company’s core offering is the ImmunoID NeXT™ Platform, which combines comprehensive tumor profiling—including whole exome, transcriptome, and T‐cell receptor sequencing—with proprietary bioinformatics to identify biomarkers and guide immuno‐oncology research. Personalis serves biopharmaceutical companies, academic institutions, and clinical research organizations seeking in‐depth insights into cancer, autoimmune diseases and other complex conditions.

In addition to its flagship ImmunoID NeXT™ Platform, Personalis offers a suite of customizable sequencing assays for biomarker discovery, clinical trial support and companion diagnostic development.